Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue Sarcoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue Sarcoma — Stella

Recruiting

Back to Soft Tissue Sarcoma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

South Korea

Severance Hospital, Seoul

Key details

Phase

Safety & dosing

Sponsor

Yonsei University

Enrollment target

~116 participants

Started

March 2024

Primary completion

December 2026

Age range

20 Years – 80 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov